Manufacture of plasma-derived products in France and measures to prevent the risk of vCJD transmission: precautionary measures and efficacy of manufacturing processes in prion removal.

@article{Flan2007ManufactureOP,
  title={Manufacture of plasma-derived products in France and measures to prevent the risk of vCJD transmission: precautionary measures and efficacy of manufacturing processes in prion removal.},
  author={Beno{\^i}t Flan and Samuel Arrabal},
  journal={Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine},
  year={2007},
  volume={14 1},
  pages={51-62}
}
The emergence of the variant Creutzfeldt-Jakob disease in the mid 1990s soon raised concerns about its possible transmission through the use of blood and plasma-derived medicinal products. A risk analysis approach was initiated by health authorities, based on updated scientific knowledge and precautionary measures were implemented in France and other countries for the management of this new possible risk. Assessment of the vCJD risk is based on epidemiology and estimates of the number of… CONTINUE READING